Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

恒赛生物成立于2018年,是致力于树突细胞疫苗(DC疫苗)研发与产业化的科技创新型企业、国家高新技术企业。公司已成功构建 Eco-DCVax 平台,旨在打破产业化技术壁垒、开发具有自主产权的全球First-in-Class的安全高效、给药便利的高品质DC疫苗产品。所开发产品——治疗性树突细胞疫苗,为复发难治性肿瘤、慢性病毒感染、自身免疫性疾病等临床亟需有效治疗手段的疾病提供治疗新途径、新策略。
恒赛生物位于上海临港蓝湾的研发中心和中试车间于2021年正式投入使用,大型研发/生产基地正在建设中。公司现已和多家国内外科研机构和三甲医院建立稳定的合作关系,开展临床研究和技术合作,以全面验证DC疫苗的临床安全性和有效性。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (17 open positions)

Manage
Note: How fast is hiring at 上海恒赛生物科技有限公司 growing? 2025: 3 openings (down 80%), 2024: 15 openings (down 29%), 2023: 21 openings (up 75%), 2022: 12 openings (flat), 2021: 12 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (19 records)

Manage
salary range: 2K - 30K, 42.1% of roles pay ¥3-10K
Note: salary statistics are based on 19 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 上海恒赛生物科技有限公司?42.1% of positions earn 3-10K, Fresh graduate salary: ¥12.5K。工厂生产类 average salary ¥8.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 工厂生产类
    36.8% of total 36.8%
  • 医疗卫生/美容保健类
    26.3% of total 26.3%
  • 生物/制药/化工/环保类
    26.3% of total 26.3%
  • 经营管理类
    26.3% of total 26.3%

Education

  • 本科
    47.4% of total 47.4%
  • 不限
    26.3% of total 26.3%
  • 大专
    10.5% of total 10.5%
  • 硕士
    10.5% of total 10.5%

Experience

  • 不限
    42.1% of total 42.1%
  • 5-10年
    21.1% of total 21.1%
  • 3-5年
    15.8% of total 15.8%
  • 1-3年
    15.8% of total 15.8%
View Detailed Analysis

What does 上海恒赛生物科技有限公司 require? Who is 上海恒赛生物科技有限公司 hiring? recruitment: 工厂生产类占比最多占36.8%,其次是医疗卫生/美容保健类占26.3%. What education can get in at ? 本科占比最多占47.4%,其次是不限占26.3%. High education required at ? 硕士占10.5%,博士占5.3%. Work experience required at ? 不限占比最多占42.1%,其次是5-10年占21.1%. Where are the job locations at ? 上海占比最多占94.7%,其次是武汉占5.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 513.83万(元)
Legal Representative: 刘慧宁
Date Established:
Credit Code: 91310112MA1GC8X00B
Registered Address: 中国(上海)自由贸易试验区临港新片区沧海路4188号43幢

People who follow this company also follow

Competitors (Similar Companies)

制药/药业 医药 维生素 葡萄糖
“Products for the diagnosis and treatment of allergic diseases”
“Adhering to the corporate culture of science and excellence, committed”
“连续多年位居国内皮肤临床用药领导地位”
制药/药业 医药 原料药 研发
“A renowned enterprise in China's liver disease and anti-tumor fields”
“The core platform of Sinopharm's Traditional Chinese Medicine industry”
制药/药业 药物研发 生物制药 医药
“一家专业从事新药研发的高新技术企业”
制药/药业 医药 医药中间体 原料药
中间体 生产 原料药 中间体生产
“Research, development, production, and sales of high-end dairy and nut”
“Promoting human health”
制药/药业 医药 医药中间体 造影剂
“Committed to the development of the pharmaceutical industry and human ”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates